[DSCO] Discovery Laboratories, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization: 31.61 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 3.5 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart DSCO

Refresh chart

Description: Discovery Laboratories, Inc., a specialty biotechnology company, focuses on developing life-saving products for critical-care patients with respiratory disease and care in pulmonary medicine. Its drug technology produces a synthetic peptide-containing surfactant (KL4 surfactant), as well as in liquid, lyophilized, and aerosolized dosage forms; and develops drug delivery technologies to enable efficient delivery of its aerosolized KL4 surfactant. The company?s product includes SURFAXIN Intratracheal suspension for the prevention of respiratory distress syndrome (RDS) in premature infants. It is also developing AEROSURF, a drug-device combination product that is in Phase IIa clinical trials for the treatment of RDS in premature infants; and AFECTAIR devices, which are novel disposable aerosol-conducting airway connectors for infants. The company has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of KL4 surfactant products in Andorra, Greece, Italy, Portugal,

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding8.19 M EPS-6.39 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -82.53% Sales Growth - Q/Q-83.87% P/E-0.55
P/E To EPS Growth P/S9.57 P/BV3.67 Price/Cash Per Share
Price/Free Cash Flow-0.68 ROA-117.42% ROE-572.98% ROI-155.07%
Current Ratio3.91 Quick Ratio Long Term Debt/Equity0.78 Debt Ratio1.18
Gross Margin5.88% Operating Margin-1458.03% Net Profit Margin-1494.52% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-20 K Cash From Investing Activities-450 K Cash From Operating Activities-8.66 M Gross Profit-740 K
Net Profit-12.18 M Operating Profit-11.17 M Total Assets38.12 M Total Current Assets36.16 M
Total Current Liabilities9.26 M Total Debt20.9 M Total Liabilities30.31 M Total Revenue190 K
Technical Data
High 52 week20.16 Low 52 week1.58 Last close3.5 Last change-9.33%
RSI84.62 Average true range0.29 Beta0.85 Volume
Simple moving average 20 days56.92% Simple moving average 50 days64.58% Simple moving average 200 days-16.68%
Performance Data
Performance Week15.51% Performance Month121.52% Performance Quart31.58% Performance Half-32.43%
Performance Year-77.68% Performance Year-to-date19.05% Volatility daily7.25% Volatility weekly16.21%
Volatility monthly33.23% Volatility yearly115.11% Relative Volume0% Average Volume82.65 K
New High New Low